Memos and Newsletters
  dason   Newsletters

10/22 - IDWeek 2022: Highlighted DCASIP Research and Abstracts

09/22 - The Search for More Meaningful Metrics: A look at Antibiotic Spectrum Scores

08/22 - Pondering Procalcitonin

07/22 - New and Revised Antibiotic Stewardship Requirements from The Joint Commission

06/22 - ß-Lactam Induced Neurotoxicity

05/22 - Bezlotoxumab: Assessing its current role in C. difficile management

04/22 - Pneumococcal vaccine update: New ACIP Recommendations

03/22 - Fosfomycin for UTI Therapy - The Secret is Leaking Out

02/22 - Use of Current Breakpoints by Clinical Laboratories - Mission Critical for Accurate Detection of Antimicrobial Resistance

01/22 - Outpatient COVID-19 Therapies: Drugs in the Time of Omicron

12/21 - Review of 2021 IDSA Guidance for the Treatment of Antimicrobial-Resistant Gram-Negative Infections: Version 2.0

11/21 - Interprofessional Communication and Engagement in Stewardship

10/21 - IDWeek 2021: Highlighted DCASIP Research and Abstracts

09/21 - Top Antimicrobial Stewardship Intervention Publications in 2020

08/21 - A Review on Diagnosis and an Update on Treatment of Urinary Tract Infections in Men

07/21 - Intraoperative irrigation – 'Do additives add any benefit?'

06/21 - Updates on the Treatment of C. difficile Infection: Highlights from the New IDSA and ACG Guidelines

05/21 - Opportunities Abound for Optimizing Antimicrobial Use in US Hospitals

04/21 - SEP-1: Easing Antibiotic Selection

03/21 - Blood Culture Contaminants: No Joke for Stewards

02/21 - Neutralizing Antibodies for Outpatient Treatment of COVID-19

01/21 - CDC Updates Gonococcal Guidelines

12/20 - COVID-19 Vaccine Q&A

11/20 - Oral Vancomycin for the Prevention of C. difficile Infection

10/20 - IDWEEK 2020: Highlighted Abstracts and DCASIP Research Presentation Synopsis

09/20 - Review of 2020 IDSA Treatment Guidance for Multidrug-Resistant Gram-negatives

08/20 - Putting Penicillin Allergies to the Test

07/20 - Part II: Dropping Empiric Vancomycin for Community-acquired Pneumonia

06/20 - Using DRIP to Drop Unnecessary Broad-Spectrum Treatments for Pneumonia

05/20 - Handshake Stewardship in the Era of COVID-19

04/20 - New Vancomycin Dosing Guidelines - Should We Switch?

03/20 - Antibiotic Stewardship During the Novel Coronavirus Pandemic

03/20 - The Evidence Behind Social Distancing

02/20 - Rapid Diagnostic Testing for Bloodstream Infections

01/20 - Cefiderocol: A first-in-class siderophore cephalosporin designed to combat resistance

12/19 - Duration of Therapy for Gram-Negative Bloodstream Infections

11/19 - Blood cultures before antibiotics - Sequence matters

10/19 - Review of the 2019 IDSA/ATS Practice Guidelines for the Management of Community-acquired Pneumonia (CAP)

09/19 - Antimicrobial Stewardship in Community Hospitals

08/19 - Prolonged Perioperative Antibiotics: Not Worth the Risk

07/19 - The Antibiotic Pipeline - Quick takes on novel agents

06/19 - Community acquired pneumonia: 3 vs 5-day course of azithromycin in combination with a beta-lactam

05/19 - Updates to the NHSN AU Option: New Standardized Antimicrobial Administration Ratio (SAAR)

04/19 - TYRX pocket- the perfect pocket?

03/19 - Are Oral Antibiotics Just as Good as Intravenous?

02/19 - Antibiogram Updates 2019

01/19 - It's That Time of Year: Flu Shots

12/18 - Preoperative S. aureus surveillance, decolonization, and the implications for SSI prevention and antibiotic prophylaxis

11/18 - Antimicrobial Stewardship Training Resources and More!

10/18 - The MERINO trial: Piperacillin-tazobactam loses out to meropenem in drug-resistant blood stream infections.

09/18 - Diagnostic Stewardship Part II: Understanding indications for collecting blood cultures for hospitalized adult patients

08/18 - Here We Go Again! FDA Updates Drug Safety Communication for Fluoroquinolones

07/18 - New Aminoglycoside on the Block: What role should Plazomicin play in the management of infectious diseases?

06/18 - To Treat or Not to Treat? How to Identify Contaminated Blood Cultures

05/18 - Diagnostic Stewardship: An alternative approach to reduce HAIs and improve clinical care

04/18 - UTI's & Asymptomatic Bacturemia in Older Adults

03/18 - C the Diff: What's New in the 2017 IDSA/SHEA Clinical Practice Guidelines for Clostridium difficile Infection

02/18 - Static versus Cidal Antibiotics

01/18 - Periarticular Injection Practices in DICON/DASON Hospitals

12/17 - Antimicrobial Stewardship Strategies for Managing the Intravenous (IV) Fluid Shortage

11/17 - The Role of the Staff Nurse in Inpatient Antimicrobial Stewardship: A Critical Stewardship Champion at the Bedside

10/17 - The role of ceftolozane/tazobactam (Zerbaxa),ceftazidime/avibactam (Avycaz), and meropenem/vaborbactam (Vabomere) in treating infections caused by MDR GNB

09/17 - Updates in Carbapenem-Resistant Enterobacteriaceae Testing

08/17 - Review of the New CDC Guidelines for the Prevention of Surgical Site Infections

07/17 - Management of Staphylococcus aureus Bacteremia in Community Hospitals

06/17 - Management of Beta-Lactam Allergies: Risk of Crossreactivity

05/17 - Diagnostic Stewardship: An alternative approach to reduce HAIs and improve clinical care

04/17 - Stewardship Tips and Tricks: Field Guide for Successfully Communicating Stewardship Recommendations

03/17 - Review of the 2017 Surgical Infection Society Guidelines on the Management of Intra-Abdominal Infection

02/17 - Anaerobic Infections and Double Anaerobic Coverage

01/17 - Treatment of Candidiasis and Antifungal Stewardship Opportunities

12/16 - Antibiotic Use in Small Community Hospitals

11/16 - Is Five the New Seven? Updated Treatment Durations for Common Infections

10/16 - The Value of Hospital-Based Antimicrobial Stewardship Programs

09/16 - Antibiotic Use in Acute Bronchitis and Acute Exacerbations of Chronic Bronchitis

08/16 - Review of the 2016 IDSA/ATS Practice Guidelines for the Management of Adults with hospital acquired (HAP) and Ventilator associated Pneumonia (VAP)

07/16 - Vancomycin and piperacillin-tazobactam Bad for your patient's kidneys?

06/16 - The dangers of fluoroquinolone use: FDA weighs in

05/16 - Spotlight on stewardship: The new IDSA/SHEA Antibiotic Stewardship Guidelines

04/16 - Navigating the CDC's Antibiotic Resistance Patient Safety Atlas

03/16 - "You cannot manage what you cannot measure": understanding nuances in antimicrobial use metrics

02/16 - Keeping track of antimicrobial usage: The Antibiotic Stewardship Assessment Portal

01/16 - A field guide: covering MRSA when treating SSTI and pneumonia

04/15 - Promoting Antibiotic Stewardship with Beta-lactam Allergy De-labeling

10/13 - Avoiding Ertapenem for Colorectal Surgery Perioperative Prophylaxis

Pharmacist's Letter Resources

Analgesics for Acute Pain

Antithrombotic Management in Regional Anesthesia

Clostridium difficile in Adults

Comparison of Insulins

Comparison of Oral Anticoagulants

Equianalgesic Dosing of Opioids for Pain Management

Heparin-Induced Thrombocytopenia

Sepsis Management in Adults: Pharmacotherapy Focus

Pharmacy Dept. Resources

Shiftwizard notes


Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Memorial Hospital.
While others may view accessible pages, Iredell Memorial Hospital makes no warranty, express or implied,
as to the use of this information outside of Iredell Memorial Hospital.
The content of this policy and procedure document serves as guidance to the delivery of quality patient care.
Care providers are expected to exercise critical thinking and situational awareness skills,
and in specific situations to take such action as is necessary for the delivery of quality patient care.